β-thalassemia heart disease: Is it time for its recognition as a distinct cardiomyopathy?

Hellenic Journal of Cardiology

Volumn 49, Issue 6, 2008, Pages 451-452

  Kremastinos, Dimitrios Th ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; IRON;

BETA THALASSEMIA; BLOOD TRANSFUSION; CARDIOMYOPATHY; CLINICAL FEATURE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; HEART CONTRACTION; HEART DILATATION; HEART DISEASE; HUMAN; IRON CHELATION; LIFE EXPECTANCY; PATHOPHYSIOLOGY; PHENOTYPE; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL RATE; THALASSEMIA MAJOR;

BETA-THALASSEMIA; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; HEART FAILURE; HUMANS; IRON OVERLOAD;

EID: 57149089710     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005; 353: 1135-1146.
2. Kremastinos DT, Tsiapras DP, Kostopoulou AG, Hamodraka ES, Chaidaroglou AS, Kapsali ED. NT-proBNP levels and diastolic dysfunction in beta-thalassaemia major patients. Eur J Heart Fail. 2007; 9: 531-536.
3. Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet. 2000; 355: 2051-2052.
4. Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med. 1994; 331: 574-578.
5. Borgna-Pignatti C, Cappellini MD, De Stefano P, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005; 1054: 40-47.
6. Davis BA, O'Sullivan C, Jarritt PH, Porter JB. Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. Blood. 2004; 104: 263-269.
7. Kremastinos DT, Tsetsos GA, Tsiapras DP, Karavolias GK, Ladis VA, Kattamis CA. Heart failure in beta thalassemia: a 5-year follow-up study. Am J Med. 2001; 111: 349-354.
8. Engle MA, Erlandson M, Smith CH. Late cardiac complications of chronic, refractory anemia with hemochromatosis. Circulation. 1964; 30: 698-705.
9. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and disease complications in thalassemia major. Ann N Y Acad Sci. 1998; 850: 227-231.
10. Ehlers KH, Levin AR, Markenson AL, et al. Longitudinal study of cardiac function in thalassemia major. Ann N Y Acad Sci. 1980; 344: 397-404.
11. Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989; 2: 27-30.
12. Kremastinos DT, Toutouzas PK, Vyssoulis GP, Venetis CA, Avgoustakis DG. Iron overload and left ventricular performance in beta thalassemia. Acta Cardiol. 1984; 39: 29-40.
13. Kremastinos DT, Tsiapras DP, Tsetsos GA, Rentoukas EI, Vretou HP, Toutouzas PK. Left ventricular diastolic Doppler characteristics in beta-thalassemia major. Circulation. 1993; 88: 1127-1135.
14. Kremastinos DT, Tiniakos G, Theodorakis GN, Katritsis DG, Toutouzas PK. Myocarditis in beta-thalassemia major. A cause of heart failure. Circulation. 1995; 91: 66-71.
15. Kremastinos DT, Flevari P, Spyropoulou M, Vrettou H, Tsiapras D, Stavropoulos-Giokas CG. Association of heart failure in homozygous beta-thalassemia with the major histocompatibility complex. Circulation. 1999; 100: 2074-2078.
16. Economou-Petersen E, Aessopos A, Kladi A, et al. Apolipoprotein E epsilon-4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia. Blood. 1998; 92: 3455-3459.
17. Bergstrom A, Anderson B, Edner M, Nylander E, Persson H, Dahlstrom U. Effects of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail. 2004; 6: 453-461.
18. Dahlstrom U. Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail. 2004; 6: 281-287.
19. Kremastinos DT. Heart failure in beta-thalassaemia: a local or universal health problem? Hellenic J Cardiol. 2007; 48: 189-190.